Objective: Caspase-1 is required for nephritis and robust autoantibody development in the pristane model of murine lupus. The objective of this study was to evaluate the immune response and to study the splenic B and T cell populations in wild-type (WT) and caspase-1 -/-mice following pristane injection in order to develop an understanding of why absence of caspase-1 is protective in pristane-induced lupus. Methods: Immunization responses to NP-Ficoll and NPovalbumin were assessed in WT and caspase-1 -/-mice. In vitro IgM and IgG responses to R848 were measured by ELISA. Serum IgM anti-dsDNA and IL-1b were also measured by ELISA. B and T cell populations 2 weeks and 6 months following pristane injection were measured by flow cytometry in WT and caspase-1 -/-mice. Results: Caspase-1 -/-mice generate equivalent IgG responses to NP-Ficoll and NP-ova antigens when compared to wild-type mice. Additionally, they secrete IgM and IgG in response to TLR7 activation. Pristane injected WT and caspase-1 -/-mice generate robust IgM anti-dsDNA responses. Caspase-1 -/-mice have a significant reduction in marginal zone B cell populations compared to WT 6 months after pristane exposure whereas T cell responses are intact in these mice. Conclusions: Caspase-1 -/-mice have intact immune responses but do not develop an expanded marginal zone B cell population in response to pristane-induced lupus. This may be one explanation for reduced IgG autoantibody production in these mice. Lupus (2016) 25, 81-87.
Introduction
Systemic lupus erythematosus (SLE) is an autoimmune syndrome affecting 72-128/100,000 individuals in the US. 1 A hallmark of SLE is the development of autoantibodies which recognize nuclear components such as dsDNA. These autoantibodies participate in the formation of immune complexes, which deposit in tissues such as the kidney and cause severe organ damage. 2 Recently, a role for the NLRP3 inflammasome in lupus pathogenesis has been described by multiple groups, as reviewed by Kahlenberg and Kaplan. 3 Activation of this protein complex results in cleavage and activation of IL-1b and IL-18. 4 Our group recently showed that in the pristane model of murine lupus, there is an essential role for caspase-1, the key enzyme within the inflammasome complex, for the development of immune complex-mediated nephritis. 5 Importantly, a reduction in IgG autoantibodies recognizing dsDNA was noted in caspase-1 -/mice exposed to pristane when compared to control. Other groups have also shown that inflammasome inhibition can improve autoantibody profiles in genetic lupus models, 6, 7 suggesting that activation of the inflammasome contributes to autoantibody development. In this manuscript, we used the pristane model of murine lupus to examine the effects of caspase-1 deficiency on B and T cell populations. and were obtained as a kind gift of Dr. Noriko Tsuji, National Institute of Advanced Industrial Science and Technology, Japan. The mice were backcrossed onto the BALB/c background for at least eight generations prior to use and bred at the University of Michigan. Wild-type (WT) BALB/c mice were acquired from Harlan and Jackson Laboratory.
Pristane injection
Eight to ten week-old mice were given a single intraperitoneal injection with either 0.5 mL sterile phosphate buffered saline (PBS) as a control or 0.5 mL sterile pristane (Sigma-Aldrich). Mice were euthanized 2 weeks or 6 months post injection.
Immunizations
Eight to ten week old BALB/c and caspase-1 -/mice were vaccinated intraperitoneally with an emulsion of 50% v/v incomplete Freund's adjuvant (Sigma-Aldrich) and either 100 mL PBS, 100 mg 4hydroxy-3-nitrophenylacetyl (NP)-Ficoll (Biosearch Technologies), or 100 mg NP-ovalbumin (Biosearch Technologies). Serum was collected by saphenous vein bleed at weekly intervals.
ELISA
Anti-dsDNA IgM, total IgM, and total IgG antibodies were quantified with commercially available kits (Alpha Diagnostic) using manufacturer protocols. NP-specific IgG antibodies were detected by ELISA with 4 mg/mL plate bound NP-BSA (bovine serum albumin), ratio > 20 (Biosearch Technologies). Serum IL-1b was measured via ELISA (E-bioscience).
B cell isolation and culture
B cells from pooled mouse spleens (n ¼ 5/group) were purified by negative selection with the EasySep mouse B cell isolation kit (Stem Cell Technologies) and cultured in RPMI 1640 with 10% FCS and 50 IU/mL penicillin/50 mg/mL streptomycin (Life Technologies) at 1 Â 10 6 cells/ well. Cultured B cells were stimulated with the TLR7/8 agonist R848 (Enzo Life Sciences) at 1 mg/mL. Four days after stimulation, supernatants were harvested for total IgG and IgM ELISAs.
Flow cytometry (surface stain, intracellular cytokine)
Samples were analyzed on an LSR II (BD Biosciences). Data was analyzed with FlowJo V10 software (Tree Star). The following antibodies were used: Pe/Cy7-conjugated anti-CD19 (6d5), FITCconjugated anti-CD21/CD35 (7E9), PE-conjugated and Pacific Blue-conjugated anti-CD23 (B3B4), PE-conjugated anti-CD138 (281-2), APC-conjugated anti-CD45R/B220 (RA3-6B2), APC-conjugated anti-CD3 (17A2), were from Biolegend. FITC-conjugated anti-CD4 (GK1.5), and FITCconjugated anti-CD8a (53-6.7) were from BD biosciences. For intracellular cytokine assays, splenocytes were incubated with cell stimulation cocktail (plus protein transport inhibitors) (eBioscience) or control splenocytes were treated with Brefeldin A solution (Biolegend) for four or 16 hours at 37 C with 5% CO 2 . Following antibody staining, splenocytes were fixed and permeabilized with Foxp3/ transcription factor staining buffer set (eBioscience) prior to labeling with PE-conjugated anti-IL-17A (TC11-18H10.1) (eBioscience).
Statistics
Mean differences between populations were compared by two-tailed Student's unpaired t-test using Prism Software version 6.01 (GraphPad).
Results
Previously, our observations had indicated that following pristane injection, caspase-1 -/-mice had significantly abrogated anti-dsDNA IgG responses when compared to WT mice. 5 To determine whether this lack of response indicated a deficiency in the general caspase-1 -/-B cell antibody response to antigens, we examined vaccine responses to T-independent (NP-Ficoll) and T-dependent (NP-ovalbumin) antigens. Incomplete Freund's adjuvant was used as it does not stimulate the inflammasome as part of activating the immune response. 8 As shown in Figure 1 (a), WT and caspase-1 -/-mice generate comparable IgG antibody responses to T-independent and T-dependent foreign antigens. These results indicate that caspase-1 is not required for B cell production of IgG in a T independent manner and that B and T cells do not require caspase-1 to mount IgG responses to protein antigens.
Generation of pristane-induced lupus is dependent on TLR7 signals, 9 so we next examined B cell responses to R848, a TLR7 ligand. Figure 1 (b) demonstrates that caspase-1 -/-CD19þ cells generated a robust and twofold greater IgM response in vitro following TLR7 stimulation when compared to WT, but both WT and caspase-1 -/- mice generated equivalent IgG responses. As we had detected decreased IgG dsDNA responses in caspase-1 -/-mice in vivo, 5 we next examined whether dsDNA IgM antibody formation was similarly affected in pristane exposed mice. Caspase-1 -/-mice produced slightly more (albeit non-significantly more) IgM dsDNA 6 months after pristane exposure when compared to WT mice (Figure 1(c) ). These data suggest that while caspase-1 -/-B cells respond to TLR7 agonists as well as or better than WT B cells, dsDNA autoantibody generation in vivo following pristane injection requires caspase-1 for robust generation of IgG but not IgM dsDNA antibodies.
In order to better understand which properties of the B cell compartment may contribute to anti-ds-DNA IgG responses following pristane exposure, we examined splenic B cell populations at two weeks and 6 months post pristane exposure. The two week time point has been used previously to understand early responses to pristane, 10, 11 and we and others have shown that WT mice develop lupus-like phenotypes, including induction of type I interferon responses, vascular damage, and increased glomerular hypercellularity and immune complex deposition, by 6 months post pristane exposure. 5, 9, 12 All of these phenotypes are abrogated in caspase-1 -/-mice. 5 The generation of IL-18, 5 and IL-1b (Figure 1(d) ), following pristane injection is also reduced in caspase-1 -/-mice. As shown in Figure 2 , the number of CD19þ cells was slightly but significantly decreased in caspase-1 -/mice two weeks after pristane exposure. However the number of follicular or marginal zone B cells did not differ significantly in WT or caspase-1 -/-mice two weeks following pristane injection. Plasma cell populations were infrequent and remained thus in the spleen at two weeks. At 6 months post pristane exposure the number of total B cells, follicular B cells, and plasma cells did not differ between WT and caspase-1 -/-mice. Surprisingly, the number of marginal zone B cells was significantly decreased in caspase-1 -/-at this time point. These data suggest that loss of marginal zone B cells, which are expanded in lupus mice and are known to secrete anti-dsDNA antibodies, 13 may contribute to decreased anti-dsDNA IgG production following pristane exposure in caspase-1-deficient mice.
T cell populations were also examined. As shown in Figure 3 , pristane induced a short-term decline in splenic CD4 and CD8 T cell populations in WT mice and a significantly greater decline in CD4 populations in caspase-1 -/-mice; however, by 6 months, no significant differences existed between PBS and pristane-exposed mice for WT or caspase-1 -/-populations (Figure 3(a) to (d) ). Th17 populations were also examined as serum IL-17 is decreased in pristane-exposed caspase-1 -/-mice 5 . As shown in Figure 3 (e), caspase-1 -/-mice had slightly more Th17 cells at baseline than WT, but upon exposure to pristane, both WT and caspase-1 -/-had equivalent Th17 populations.
Discussion
Several murine models have now demonstrated an important role of the inflammasome in lupus, including the development of nephritis and IgG anti-dsDNA antibodies. [5] [6] [7] Here, we report that caspase-1 is not required for non-dsDNA antibody responses to T-dependent and T-independent antigens. We also found that caspase-1 is not required for the development of IgM anti-dsDNA antibodies, but is necessary for the maintenance, and possible expansion, of the marginal zone B cell population following pristane exposure.
Marginal zone B cells express high levels of TLRs and polyreactive B-cell receptors which allow them to generate antibody responses to circulating products in a rapid fashion. 14 This population is expanded in lupus-prone mice and secretes anti-dsDNA antibodies. 13 Stimulation of marginal zone B cells by TLRs, including TLR7, results in plasmablast differentiation and IgM production as well as generation of class-switched IgG responses. 15 Our data detects a trend for expansion of marginal zone B cells following long-term pristane exposure, consistent with a role of these cells in pristane-induced lupus. However, this expansion is absent in caspase-1 -/-mice, which may explain the decrease in IgG dsDNA antibodies following pristane exposure.
The mechanism by which caspase-1 is required for marginal zone B cell expansion may be explained by its activation of IL-18. Recently, a role for IL-18 in proliferation and class switching of the marginal zone B cell population was identified. 16 We had previously shown that IL-18 is increased in WT, but not caspase-1 -/-mice following pristane injection, consistent with the role of caspase-1 in IL-18 activation. 5 Thus, absence of IL-18 activation may explain the dramatic decrease in marginal zone B cell populations in caspase-1 -/mice following lupus induction with pristane and serve as a possible explanation for reduced production of anti-dsDNA IgG antibodies. Alternatively, the reduction of IL-18 and IL-1b production in marginal zone macrophages and dendritic cells in 
